These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18940405)

  • 1. Author reply: phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.
    Kleefstra N; Houweling ST; Groenier KH; Bilo HJ
    Metabolism; 2008 Nov; 57(11):1623-4. PubMed ID: 18940405
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes: response to Martin et al.
    Mark DA
    Diabetes Care; 2006 Dec; 29(12):2764; author reply 2764-5. PubMed ID: 17130232
    [No Abstract]   [Full Text] [Related]  

  • 3. Author reply: Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
    Cefalu WT
    Metabolism; 2010 Nov; 59(11):e18-9. PubMed ID: 20974311
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
    Kleefstra N; Houweling ST; Groenier KH; Bilo HJ
    Metabolism; 2010 Nov; 59(11):e17. PubMed ID: 20813383
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating.
    Brownley KA; Boettiger CA; Young L; Cefalu WT
    Med Hypotheses; 2015 Jul; 85(1):45-8. PubMed ID: 25838140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the biochemistry of chromium(III).
    Vincent JB
    Biol Trace Elem Res; 2004; 99(1-3):1-16. PubMed ID: 15235137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus.
    Morris BW; Kouta S; Robinson R; MacNeil S; Heller S
    Diabet Med; 2000 Sep; 17(9):684-5. PubMed ID: 11051290
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromium and diabetes.
    Anderson RA
    Nutrition; 1999 Sep; 15(9):720-2. PubMed ID: 10467621
    [No Abstract]   [Full Text] [Related]  

  • 9. Research profile. Chromium. Can it help kids with type 2? Sushil K. Jain, PhD.
    Kordella T
    Diabetes Forecast; 2004 Jul; 57(7):83-5. PubMed ID: 15295811
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical studies that have influenced the treatment of diabetes].
    Olsovský J
    Vnitr Lek; 2009 Apr; 55(4):349-53. PubMed ID: 19449748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus.
    Gilbert MP; Pratley RE
    Eur J Intern Med; 2009 Jul; 20 Suppl 2():S309-18. PubMed ID: 19580950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?
    Corona G; Mannucci E; Forti G; Maggi M
    Int J Androl; 2009 Oct; 32(5):431-41. PubMed ID: 19538523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining insulin therapy in type 2 diabetes mellitus.
    Rosenstock J
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):21-9. PubMed ID: 19667676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus.
    Mazziotti G; Bossoni S; Orini S; Salimbeni P; Gazzaruso C; Solerte BS; Vescovi P; Romanelli G; Giustina A
    J Am Geriatr Soc; 2009 Mar; 57(3):562-4. PubMed ID: 19278401
    [No Abstract]   [Full Text] [Related]  

  • 17. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it time to test metformin in breast cancer prevention trials? A reply to the authors.
    Barba M; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2565; author reply 2565. PubMed ID: 19745224
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Response to Nathan et al.
    Cobitz AR; Ambery P
    Diabetes Care; 2009 May; 32(5):e58; author rely e59. PubMed ID: 19407068
    [No Abstract]   [Full Text] [Related]  

  • 20. Associations among slipped capital femoral epiphysis, tibia vara, and type 2 juvenile diabetes.
    Bowen JR; Assis M; Sinha K; Hassink S; Littleton A
    J Pediatr Orthop; 2009 Jun; 29(4):341-4. PubMed ID: 19461374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.